{"id":"https://openalex.org/W1972909284","doi":"https://doi.org/10.3389/fmicb.2012.00277","title":"Origin, diversity, and maturation of human antiviral antibodies analyzed by high-throughput sequencing","display_name":"Origin, diversity, and maturation of human antiviral antibodies analyzed by high-throughput sequencing","publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W1972909284","doi":"https://doi.org/10.3389/fmicb.2012.00277","mag":"1972909284","pmid":"https://pubmed.ncbi.nlm.nih.gov/22876240","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3410596"},"language":"en","primary_location":{"id":"doi:10.3389/fmicb.2012.00277","doi":"https://doi.org/10.3389/fmicb.2012.00277","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmicb.2012.00277","pdf_url":"https://www.frontiersin.org/articles/10.3389/fmicb.2012.00277/pdf","source":{"id":"https://openalex.org/S2484704948","display_name":"Frontiers in Microbiology","issn_l":"1664-302X","issn":["1664-302X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Microbiology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fmicb.2012.00277/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019558229","display_name":"Ponraj Prabakaran","orcid":"https://orcid.org/0000-0002-4049-4813","observed_orcids":["https://orcid.org/0000-0002-4049-4813"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]},{"id":"https://openalex.org/I880747138","display_name":"Science Applications International Corporation (United States)","ror":"https://ror.org/00zv91802","country_code":"US","type":"company","lineage":["https://openalex.org/I880747138"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ponraj Prabakaran","raw_affiliation_strings":["CCR Nanobiology Program, Protein Interactions Group, Frederick National Laboratory for Cancer Research, National Institutes of Health (NIH), Frederick MD, USA","Frederick National Laboratory for Cancer Research, National Institutes of Health, CCR Nanobiology Program, Bldg 469, Rm 140, Frederick, 21702, United States","Science Applications International Corporation-Frederick, Inc, Basic Research Program, Frederick, 21702, MD, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CCR Nanobiology Program, Protein Interactions Group, Frederick National Laboratory for Cancer Research, National Institutes of Health (NIH), Frederick MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210149717"]},{"raw_affiliation_string":"Frederick National Laboratory for Cancer Research, National Institutes of Health, CCR Nanobiology Program, Bldg 469, Rm 140, Frederick, 21702, United States","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210149717"]},{"raw_affiliation_string":"Science Applications International Corporation-Frederick, Inc, Basic Research Program, Frederick, 21702, MD, United States","institution_ids":["https://openalex.org/I880747138"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103021613","display_name":"Zhongyu Zhu","orcid":"https://orcid.org/0000-0001-8384-4142","observed_orcids":["https://orcid.org/0000-0001-8384-4142"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhongyu Zhu","raw_affiliation_strings":["Frederick National Laboratory for Cancer Research, National Institutes of Health, CCR Nanobiology Program, Bldg 469, Rm 140, Frederick, 21702, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Frederick National Laboratory for Cancer Research, National Institutes of Health, CCR Nanobiology Program, Bldg 469, Rm 140, Frederick, 21702, United States","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210149717"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067025401","display_name":"Weizao Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Weizao Chen","raw_affiliation_strings":["Frederick National Laboratory for Cancer Research, National Institutes of Health, CCR Nanobiology Program, Bldg 469, Rm 140, Frederick, 21702, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Frederick National Laboratory for Cancer Research, National Institutes of Health, CCR Nanobiology Program, Bldg 469, Rm 140, Frederick, 21702, United States","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210149717"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111782319","display_name":"Rui Gong","orcid":"https://orcid.org/0000-0001-9222-5642","observed_orcids":["https://orcid.org/0000-0001-9222-5642"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rui Gong","raw_affiliation_strings":["Frederick National Laboratory for Cancer Research, National Institutes of Health, CCR Nanobiology Program, Bldg 469, Rm 140, Frederick, 21702, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Frederick National Laboratory for Cancer Research, National Institutes of Health, CCR Nanobiology Program, Bldg 469, Rm 140, Frederick, 21702, United States","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210149717"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112690536","display_name":"Yang Feng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yang Feng","raw_affiliation_strings":["Frederick National Laboratory for Cancer Research, National Institutes of Health, CCR Nanobiology Program, Bldg 469, Rm 140, Frederick, 21702, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Frederick National Laboratory for Cancer Research, National Institutes of Health, CCR Nanobiology Program, Bldg 469, Rm 140, Frederick, 21702, United States","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210149717"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013499224","display_name":"Emily D. Streaker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]},{"id":"https://openalex.org/I880747138","display_name":"Science Applications International Corporation (United States)","ror":"https://ror.org/00zv91802","country_code":"US","type":"company","lineage":["https://openalex.org/I880747138"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emily Streaker","raw_affiliation_strings":["Frederick National Laboratory for Cancer Research, National Institutes of Health, CCR Nanobiology Program, Bldg 469, Rm 140, Frederick, 21702, United States","Science Applications International Corporation-Frederick, Inc, Basic Research Program, Frederick, 21702, MD, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Frederick National Laboratory for Cancer Research, National Institutes of Health, CCR Nanobiology Program, Bldg 469, Rm 140, Frederick, 21702, United States","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210149717"]},{"raw_affiliation_string":"Science Applications International Corporation-Frederick, Inc, Basic Research Program, Frederick, 21702, MD, United States","institution_ids":["https://openalex.org/I880747138"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089862290","display_name":"Dimiter Stanchev Dimitrov","orcid":"https://orcid.org/0000-0002-2258-1024","observed_orcids":["https://orcid.org/0000-0002-2258-1024"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dimiter S. Dimitrov","raw_affiliation_strings":["Frederick National Laboratory for Cancer Research, National Institutes of Health, CCR Nanobiology Program, Bldg 469, Rm 140, Frederick, 21702, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Frederick National Laboratory for Cancer Research, National Institutes of Health, CCR Nanobiology Program, Bldg 469, Rm 140, Frederick, 21702, United States","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210149717"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5019558229"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210149717","https://openalex.org/I880747138"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":4.3474,"has_fulltext":true,"cited_by_count":35,"citation_normalized_percentile":{"value":0.93795141,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"3","issue":null,"first_page":"277","last_page":"277"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.8715999722480774,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.8715999722480774,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.05920000001788139,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.01899999938905239,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/broadly-neutralizing-antibodies","display_name":"broadly neutralizing antibodies","score":0.8410000205039978},{"id":"https://openalex.org/keywords/hiv-1","display_name":"HIV-1","score":0.875},{"id":"https://openalex.org/keywords/antibody-maturation","display_name":"antibody maturation","score":0.7639999985694885},{"id":"https://openalex.org/keywords/somatic-hypermutation","display_name":"somatic hypermutation","score":0.9110000133514404},{"id":"https://openalex.org/keywords/henipavirus","display_name":"henipaviruses","score":0.8820000290870667},{"id":"https://openalex.org/keywords/antibody-evolution","display_name":"antibody evolution","score":0.4050000011920929},{"id":"https://openalex.org/keywords/vaccine-immunogen-design","display_name":"vaccine immunogen design","score":0.699999988079071},{"id":"https://openalex.org/keywords/therapeutic-antibodies","display_name":"therapeutic antibodies","score":0.875}],"concepts":[{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.7839008569717407},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.7126936316490173},{"id":"https://openalex.org/C109825262","wikidata":"https://www.wikidata.org/wiki/Q1139164","display_name":"Germline","level":3,"score":0.6926003694534302},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.6313998699188232},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.5955410003662109},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5725962519645691},{"id":"https://openalex.org/C134305767","wikidata":"https://www.wikidata.org/wiki/Q725508","display_name":"Somatic cell","level":3,"score":0.45273298025131226},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.44189125299453735},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.41766414046287537},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.37042176723480225},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.22776946425437927}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.3389/fmicb.2012.00277","doi":"https://doi.org/10.3389/fmicb.2012.00277","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmicb.2012.00277","pdf_url":"https://www.frontiersin.org/articles/10.3389/fmicb.2012.00277/pdf","source":{"id":"https://openalex.org/S2484704948","display_name":"Frontiers in Microbiology","issn_l":"1664-302X","issn":["1664-302X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Microbiology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2419072","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3410596","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3410596","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3410596","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Microbiol","raw_type":"Text"},{"id":"pmid:22876240","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22876240","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in microbiology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:0ade4200150743f3a3f2fcaa9472d5b4","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/0ade4200150743f3a3f2fcaa9472d5b4","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Microbiology, Vol 3 (2012)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fmicb.2012.00277","doi":"https://doi.org/10.3389/fmicb.2012.00277","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmicb.2012.00277","pdf_url":"https://www.frontiersin.org/articles/10.3389/fmicb.2012.00277/pdf","source":{"id":"https://openalex.org/S2484704948","display_name":"Frontiers in Microbiology","issn_l":"1664-302X","issn":["1664-302X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Microbiology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.8560000061988831,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1079743861","display_name":null,"funder_award_id":"CO-12400","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G174812244","display_name":"DCTD Computer Support","funder_award_id":"n01co12400-79-0-22","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G1799052500","display_name":null,"funder_award_id":"N01-CO-012400","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G2310148225","display_name":null,"funder_award_id":"NO1-CO12400","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G4865969775","display_name":null,"funder_award_id":"NO1\u2010CO\u201012400","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320306085","display_name":"U.S. Department of Health and Human Services","ror":"https://ror.org/033jnv181"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1972909284.pdf","grobid_xml":"https://content.openalex.org/works/W1972909284.grobid-xml"},"referenced_works_count":20,"referenced_works":["https://openalex.org/W150036197","https://openalex.org/W199166898","https://openalex.org/W1483247593","https://openalex.org/W1991436594","https://openalex.org/W2006762166","https://openalex.org/W2038535315","https://openalex.org/W2039919570","https://openalex.org/W2051364248","https://openalex.org/W2062537390","https://openalex.org/W2068310820","https://openalex.org/W2080089116","https://openalex.org/W2093985842","https://openalex.org/W2115137014","https://openalex.org/W2131859684","https://openalex.org/W2132247062","https://openalex.org/W2159376668","https://openalex.org/W2164807254","https://openalex.org/W2338760001","https://openalex.org/W4248734872","https://openalex.org/W4392145873"],"related_works":["https://openalex.org/W2093985842","https://openalex.org/W2045644330","https://openalex.org/W2117470153","https://openalex.org/W2223987466","https://openalex.org/W2089216532","https://openalex.org/W2324970472","https://openalex.org/W2580331829","https://openalex.org/W1574042791","https://openalex.org/W7100105379","https://openalex.org/W2046943854"],"abstract_inverted_index":{"Our":[0],"understanding":[1,213],"of":[2,45,80,111,116,138,163,224,238],"how":[3],"antibodies":[4,35,82,119,126],"are":[5,175],"generated":[6],"and":[7,14,26,28,133,159,182,190,195,203,217,242],"function":[8],"could":[9,63,228],"help":[10],"develop":[11],"effective":[12,97,239],"vaccines":[13],"antibody-based":[15,243],"therapeutics":[16],"against":[17,37,127,179],"viruses":[18,30,184],"such":[19,46],"as":[20,185],"HIV-1,":[21],"SARS":[22,128],"coronavirus":[23],"(SARS":[24],"CoV),":[25],"Hendra":[27],"Nipah":[29],"(henipaviruses).":[31],"Although":[32],"broadly":[33],"neutralizing":[34],"(bnAbs)":[36],"the":[38,70,84,107,143,148,180,214,236],"HIV-1":[39,62,181],"were":[40],"observed":[41,186],"in":[42,187],"patients,":[43],"elicitation":[44],"bnAbs":[47,178,226],"remains":[48],"a":[49,66,112,160],"major":[50],"challenge":[51],"when":[52],"compared":[53,191],"to":[54,68,74,83,92,177,221,235],"other":[55,183],"viral":[56],"targets.":[57],"We":[58,140],"previously":[59],"hypothesized":[60],"that":[61,87,142,174,227],"have":[64,151],"evolved":[65],"strategy":[67],"evade":[69],"immune":[71,98],"system":[72],"due":[73],"absent":[75],"or":[76],"very":[77],"weak":[78],"binding":[79],"germline":[81,153],"conserved":[85],"epitopes":[86],"may":[88],"not":[89],"be":[90,229],"sufficient":[91],"initiate":[93],"and/or":[94],"maintain":[95],"an":[96],"response.":[99],"To":[100],"further":[101],"explore":[102],"our":[103],"hypothesis,":[104],"we":[105,169],"used":[106,123],"454":[108,149],"sequence":[109],"analysis":[110,208],"large":[113],"na\u00efve":[114],"library":[115],"human":[117,144],"IgM":[118,145],"which":[120],"had":[121],"been":[122],"for":[124,212,231],"selecting":[125],"CoV":[129],"receptor-binding":[130],"domain":[131],"(RBD),":[132],"soluble":[134],"G":[135],"proteins":[136],"(sG)":[137],"henipaviruses.":[139],"found":[141],"repertoires":[146],"from":[147],"sequencing":[150],"diverse":[152],"usages,":[154],"recombination":[155],"patterns,":[156],"junction":[157],"diversity,":[158],"lower":[161],"extent":[162],"somatic":[164,196],"mutation.":[165],"In":[166],"this":[167],"study,":[168],"identified":[170],"antibody":[171],"maturation":[172,222],"intermediates":[173],"related":[176,220],"normal":[188],"individuals,":[189],"their":[192],"genetic":[193,216],"diversity":[194],"mutation":[197],"level":[198],"along":[199],"with":[200],"available":[201],"structural":[202],"functional":[204],"data.":[205],"Further":[206],"computational":[207],"will":[209],"provide":[210],"framework":[211],"underlying":[215],"molecular":[218],"determinants":[219],"pathways":[223],"antiviral":[225],"useful":[230],"applying":[232],"novel":[233],"approaches":[234],"design":[237],"vaccine":[240],"immunogens":[241],"therapeutics.":[244]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2016-06-24T00:00:00"}